Advances in prognostic models for osteosarcoma risk

被引:2
|
作者
Yao, Yi [1 ,2 ]
Wang, Dapeng [1 ]
Zheng, Li [1 ,2 ,4 ]
Zhao, Jinmin [1 ,2 ,3 ]
Tan, Manli [1 ,2 ,4 ]
机构
[1] Guangxi Med Univ, Guangxi Engn Ctr Biomed Mat Tissue & Organ Regene, Affiliated Hosp 1, Nanning 530021, Peoples R China
[2] Guangxi Med Univ, Affiliated Hosp 1, Collaborat Innovat Ctr Regenerat Med & Med Bioreso, Nanning 530021, Peoples R China
[3] Guangxi Med Univ, Dept Orthoped, Affiliated Hosp 1, Nanning 530021, Peoples R China
[4] Guangxi Med Univ, Life Sci Inst, Nanning 530021, Peoples R China
基金
中国国家自然科学基金;
关键词
Osteosarcoma; Risk -prognosis model; TUMOR-SUPPRESSOR; CELL-PROLIFERATION; OVARIAN CANCERS; DNA METHYLATION; DOWN-REGULATION; UP-REGULATION; EXPRESSION; PROTEIN; INVASION; RECEPTORS;
D O I
10.1016/j.heliyon.2024.e28493
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The risk prognosis model is a statistical model that uses a set of features to predict whether an individual will develop a specific disease or clinical outcome. It can be used in clinical practice to stratify disease severity and assess risk or prognosis. With the advancement of large-scale secondgeneration sequencing technology, along Prognosis models for osteosarcoma are increasingly being developed as large-scale second-generation sequencing technology advances and clinical and biological data becomes more abundant. This expansion greatly increases the number of prognostic models and candidate genes suitable for clinical use. This article will present the predictive effects and reliability of various prognosis models, serving as a reference for their evaluation and application.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Prediction Of Readmission: ICU Risk & Prognostic Models
    Arsenault, K. A.
    Hamielec, C. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [22] Prognostic factors in osteosarcoma.
    Babin-Boilletot, A
    ANNALES DE PEDIATRIE, 1998, 45 (04): : 265 - 271
  • [23] Identification of Prognostic RBPs in Osteosarcoma
    Li, Bei
    Fang, Long
    Wang, Baolong
    Yang, Zengkun
    Zhao, Tingbao
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2021, 20
  • [24] AGE AS PROGNOSTIC FACTOR IN OSTEOSARCOMA
    Hagleitner, Melanie
    Hoogerbrugge, Peter
    Flucke, Uta
    Schreuder, Bart
    van de Luijtgaarden, Addy
    van der Graaf, Winette
    Loo, Maroeska Te
    PEDIATRIC BLOOD & CANCER, 2009, 53 (05) : 795 - 796
  • [25] UNRELIABILITY OF PROGNOSTIC CRITERIA IN OSTEOSARCOMA
    GRAVANIS, MB
    WHITESID.TE
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1970, 53 (01) : 15 - &
  • [26] CLINICAL PROGNOSTIC FACTORS IN OSTEOSARCOMA
    SIMON, R
    CANCER TREATMENT REPORTS, 1978, 62 (02): : 193 - 197
  • [27] Animal models in osteosarcoma
    Guijarro, Maria V.
    Ghivizzani, Steven C.
    Gibbs, C. Parker
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [28] Construction of a prognostic risk score model based on the ARHGAP family to predict the survival of osteosarcoma
    Liu, Wenda
    Xia, Kezhou
    Zheng, Di
    Huang, Xinghan
    Wei, Zhun
    Wei, Zicheng
    Guo, Weichun
    BMC CANCER, 2023, 23 (01)
  • [29] Construction of a prognostic risk score model based on the ARHGAP family to predict the survival of osteosarcoma
    Wenda Liu
    Kezhou Xia
    Di Zheng
    Xinghan Huang
    Zhun Wei
    Zicheng Wei
    Weichun Guo
    BMC Cancer, 23
  • [30] Prognostic factors in osteosarcoma. The arguments for risk adapted up-front treatment
    Machak, G.
    Bokhian, B.
    Kochergina, N.
    Senko, O.
    Aliev, M.
    EJC SUPPLEMENTS, 2007, 5 (04): : 406 - 407